Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes

作者：Qi Lu^*; Cornelis Marilyn C; Kraft Peter; Jensen Majken; van Dam Rob M; Sun Qi; Girman Cynthia J; Laurie Cathy C; Mirel Daniel B; Hunter David J; Rimm Eric; Hu Frank B

来源：Human Molecular Genetics, 2010, 19(9): 1856-1862.

DOI：10.1093/hmg/ddq057

Blood soluble E-selectin (sE-selectin) levels have been related to various conditions such as type 2 diabetes. We performed a genome-wide association study among women of European ancestry from the Nurses' Health Study, and identified genome-wide significant associations between a cluster of markers at the ABO locus (9q34) and plasma sE-selectin concentration. The strongest association was with rs651007, which explained similar to 9.71% of the variation in sE-selectin concentrations. SNP rs651007 was also nominally associated with soluble intracellular cell adhesion molecule-1 (sICAM-1) (P = 0.026) and TNF-R2 levels (P = 0.018), independent of sE-selectin. In addition, the genetic-inferred ABO blood group genotypes were associated with sE-selectin concentrations (P = 3.55 x 10(-47)). Moreover, we found that the genetic-inferred blood group B was associated with a decreased risk (OR = 0.44, 0.27-0.70) of type 2 diabetes compared with blood group O, adjusting for sE-selectin, sICAM-1, TNF-R2 and other covariates. Our findings indicate that the genetic variants at ABO locus affect plasma sE-selectin levels and diabetes risk. The genetic associations with diabetes risk were independent of sE-selectin levels.

• 出版日期2010-5-1